0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Inflammatory Bowel Disease Therapy Market Size, Status and Forecast 2019-2025
Published Date: October 2019
|
Report Code: QYRE-Auto-13A430
Home | Market Reports | Health | Health Conditions
Global Inflammatory Bowel Disease Therapy Market Size Status and Forecast 2019 2025

Global Inflammatory Bowel Disease Therapy Market Size, Status and Forecast 2019-2025

Code: QYRE-Auto-13A430
Report
October 2019
Pages:97
QYResearch
Description
Table of Content
Tables & Figures
Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not clear, clinical symptoms are not specific, easy to be confused with other diseases, so the diagnosis is more difficult.Once misdiagnosis is caused by mistreatment, the result is mild but not cured, serious is life-threatening.The diagnosis of inflammatory bowel disease mainly includes the collection of clinical history, colonoscopy, imaging and mucosal histology.
In 2018, the global Inflammatory Bowel Disease Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Inflammatory Bowel Disease Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Inflammatory Bowel Disease Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
    Johnson & Johnson
    AbbVie
    Takeda Pharmaceutical Company
    Abbott
    Celgene Corporation
    Innovate Biopharma
    Cosmo Pharmaceuticals
    Gilead Sciences
    Pfizer
Market segment by Type, the product can be split into
    Ulcerative Colitis
    Crohns Disease
    Others
Market segment by Application, split into
    Hospital
    Medical Research Organization
    Other
Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America
The study objectives of this report are:
    To analyze global Inflammatory Bowel Disease Therapy status, future forecast, growth opportunity, key market and key players.
    To present the Inflammatory Bowel Disease Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Inflammatory Bowel Disease Therapy are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Ulcerative Colitis
1.4.3 Crohns Disease
1.4.4 Others
1.5 Market by Application
1.5.1 Global Inflammatory Bowel Disease Therapy Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Medical Research Organization
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Inflammatory Bowel Disease Therapy Market Size
2.2 Inflammatory Bowel Disease Therapy Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease Therapy Market Size by Regions (2019-2025)
2.2.2 Inflammatory Bowel Disease Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Inflammatory Bowel Disease Therapy Market Size by by Players
3.1.1 Global Inflammatory Bowel Disease Therapy Revenue by by Players (2014-2019)
3.1.2 Global Inflammatory Bowel Disease Therapy Revenue Market Share by by Players (2014-2019)
3.1.3 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Inflammatory Bowel Disease Therapy Key Players Head office and Area Served
3.3 Key Players Inflammatory Bowel Disease Therapy Product/Solution/Service
3.4 Date of Enter into Inflammatory Bowel Disease Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Inflammatory Bowel Disease Therapy Market Size by Type (2014-2019)
4.2 Global Inflammatory Bowel Disease Therapy Market Size by Application (2014-2019)
5 North America
5.1 North America Inflammatory Bowel Disease Therapy Market Size (2014-2019)
5.2 Inflammatory Bowel Disease Therapy Key Players in North America
5.3 North America Inflammatory Bowel Disease Therapy Market Size by Type
5.4 North America Inflammatory Bowel Disease Therapy Market Size by Application
6 Europe
6.1 Europe Inflammatory Bowel Disease Therapy Market Size (2014-2019)
6.2 Inflammatory Bowel Disease Therapy Key Players in Europe
6.3 Europe Inflammatory Bowel Disease Therapy Market Size by Type
6.4 Europe Inflammatory Bowel Disease Therapy Market Size by Application
7 China
7.1 China Inflammatory Bowel Disease Therapy Market Size (2014-2019)
7.2 Inflammatory Bowel Disease Therapy Key Players in China
7.3 China Inflammatory Bowel Disease Therapy Market Size by Type
7.4 China Inflammatory Bowel Disease Therapy Market Size by Application
8 Japan
8.1 Japan Inflammatory Bowel Disease Therapy Market Size (2014-2019)
8.2 Inflammatory Bowel Disease Therapy Key Players in Japan
8.3 Japan Inflammatory Bowel Disease Therapy Market Size by Type
8.4 Japan Inflammatory Bowel Disease Therapy Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Inflammatory Bowel Disease Therapy Market Size (2014-2019)
9.2 Inflammatory Bowel Disease Therapy Key Players in Southeast Asia
9.3 Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Type
9.4 Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Application
10 India
10.1 India Inflammatory Bowel Disease Therapy Market Size (2014-2019)
10.2 Inflammatory Bowel Disease Therapy Key Players in India
10.3 India Inflammatory Bowel Disease Therapy Market Size by Type
10.4 India Inflammatory Bowel Disease Therapy Market Size by Application
11 Central & South America
11.1 Central & South America Inflammatory Bowel Disease Therapy Market Size (2014-2019)
11.2 Inflammatory Bowel Disease Therapy Key Players in Central & South America
11.3 Central & South America Inflammatory Bowel Disease Therapy Market Size by Type
11.4 Central & South America Inflammatory Bowel Disease Therapy Market Size by Application
12 International Players Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Details
12.1.2 Company Description and Business Overview
12.1.3 Inflammatory Bowel Disease Therapy Introduction
12.1.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019))
12.1.5 Johnson & Johnson Recent Development
12.2 AbbVie
12.2.1 AbbVie Company Details
12.2.2 Company Description and Business Overview
12.2.3 Inflammatory Bowel Disease Therapy Introduction
12.2.4 AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.2.5 AbbVie Recent Development
12.3 Takeda Pharmaceutical Company
12.3.1 Takeda Pharmaceutical Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Inflammatory Bowel Disease Therapy Introduction
12.3.4 Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.3.5 Takeda Pharmaceutical Company Recent Development
12.4 Abbott
12.4.1 Abbott Company Details
12.4.2 Company Description and Business Overview
12.4.3 Inflammatory Bowel Disease Therapy Introduction
12.4.4 Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.4.5 Abbott Recent Development
12.5 Celgene Corporation
12.5.1 Celgene Corporation Company Details
12.5.2 Company Description and Business Overview
12.5.3 Inflammatory Bowel Disease Therapy Introduction
12.5.4 Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.5.5 Celgene Corporation Recent Development
12.6 Innovate Biopharma
12.6.1 Innovate Biopharma Company Details
12.6.2 Company Description and Business Overview
12.6.3 Inflammatory Bowel Disease Therapy Introduction
12.6.4 Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.6.5 Innovate Biopharma Recent Development
12.7 Cosmo Pharmaceuticals
12.7.1 Cosmo Pharmaceuticals Company Details
12.7.2 Company Description and Business Overview
12.7.3 Inflammatory Bowel Disease Therapy Introduction
12.7.4 Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.7.5 Cosmo Pharmaceuticals Recent Development
12.8 Gilead Sciences
12.8.1 Gilead Sciences Company Details
12.8.2 Company Description and Business Overview
12.8.3 Inflammatory Bowel Disease Therapy Introduction
12.8.4 Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.8.5 Gilead Sciences Recent Development
12.9 Pfizer
12.9.1 Pfizer Company Details
12.9.2 Company Description and Business Overview
12.9.3 Inflammatory Bowel Disease Therapy Introduction
12.9.4 Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2014-2019)
12.9.5 Pfizer Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Detail
List of Tables and Figures
    Table Inflammatory Bowel Disease Therapy Key Market Segments
    Table Key Players Inflammatory Bowel Disease Therapy Covered
    Table Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type 2018-2025 (Million US$)
    Figuer Ulcerative Colitis Figures
    Table Key Players of Ulcerative Colitis
    Figuer Crohns Disease Figures
    Table Key Players of Crohns Disease
    Figuer Others Figures
    Table Key Players of Others
    Table Global Inflammatory Bowel Disease Therapy Market Size Growth by Application 2019-2025 (Million US$)
    Figure Global Inflammatory Bowel Disease Therapy Market Share by Application in 2018 & 2025
    Figure Hospital Case Studies
    Figure Medical Research Organization Case Studies
    Figure Other Case Studies
    Figure Inflammatory Bowel Disease Therapy Report Years Considered
    Figure Global Inflammatory Bowel Disease Therapy Market Size and Growth Rate 2014-2025 (Million US$)
    Table Global Inflammatory Bowel Disease Therapy Market Size by Regions 2019-2025 (Million US$)
    Table Global Inflammatory Bowel Disease Therapy Market Size by Regions 2019-2025 (Million US$)
    Table Global Inflammatory Bowel Disease Therapy Market Share by Regions 2014-2019
    Figure Global Inflammatory Bowel Disease Therapy Market Share by Regions 2014-2019
    Figure Global Inflammatory Bowel Disease Therapy Market Share by Regions in 2018
    Table Market Top Trends
    Table Key Drivers: Impact Analysis (2019-2025)
    Table Key Challenges
    Figure PORTER'S FIVE FORCES ANALYSIS
    Table Global Inflammatory Bowel Disease Therapy Revenue by by Players (2014-2019) (Million US$)
    Table Global Inflammatory Bowel Disease Therapy Market Share by by Players (2014-2019)
    Figure Global Inflammatory Bowel Disease Therapy Market Share by by Players in 2018
    Table Global Inflammatory Bowel Disease Therapy by Players Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Inflammatory Bowel Disease Therapy Product/Solution/Service
    Table Date of Enter into Inflammatory Bowel Disease Therapy Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Inflammatory Bowel Disease Therapy Market Size by Type (2014-2019) (Million US$)
    Table Global Inflammatory Bowel Disease Therapy Market Size Share by Type (2014-2019)
    Figure Global Inflammatory Bowel Disease Therapy Market Size Market Share by Type (2014-2019)
    Table Global Inflammatory Bowel Disease Therapy Market Size by Application (2014-2019) (Million US$)
    Table Global Inflammatory Bowel Disease Therapy Market Size Share by Application (2014-2019)
    Figure Global Inflammatory Bowel Disease Therapy Market Size Market Share by Application (2014-2019)
    Figure Global Inflammatory Bowel Disease Therapy Revenue Market Share by Application in 2018
    Figure North America Inflammatory Bowel Disease Therapy Market Size 2014-2019 (Million US$)
    Table North America Key Players Inflammatory Bowel Disease Therapy Revenue (2018-2019) (Million US$)
    Table North America Key Players Inflammatory Bowel Disease Therapy Market Share (2018-2019)
    Table North America Inflammatory Bowel Disease Therapy Market Size by Type 2014-2019 (Million US$)
    Table North America Inflammatory Bowel Disease Therapy Market Share by Type 2014-2019
    Table North America Inflammatory Bowel Disease Therapy Market Size by Application 2014-2019 (Million US$)
    Table North America Inflammatory Bowel Disease Therapy Market Share by Application 2014-2019
    Figure Europe Inflammatory Bowel Disease Therapy Market Size 2014-2019 (Million US$)
    Table Europe Key Players Inflammatory Bowel Disease Therapy Revenue (2018-2019) (Million US$)
    Table Europe Key Players Inflammatory Bowel Disease Therapy Market Share (2018-2019)
    Table Europe Inflammatory Bowel Disease Therapy Market Size by Type 2014-2019 (Million US$)
    Table Europe Inflammatory Bowel Disease Therapy Market Share by Type 2014-2019
    Table Europe Inflammatory Bowel Disease Therapy Market Size by Application 2014-2019 (Million US$)
    Table Europe Inflammatory Bowel Disease Therapy Market Share by Application 2014-2019
    Figure China Inflammatory Bowel Disease Therapy Market Size 2014-2019 (Million US$)
    Table China Key Players Inflammatory Bowel Disease Therapy Revenue (2018-2019) (Million US$)
    Table China Key Players Inflammatory Bowel Disease Therapy Market Share (2018-2019)
    Table China Inflammatory Bowel Disease Therapy Market Size by Type 2014-2019 (Million US$)
    Table China Inflammatory Bowel Disease Therapy Market Share by Type 2014-2019
    Table China Inflammatory Bowel Disease Therapy Market Size by Application 2014-2019 (Million US$)
    Table China Inflammatory Bowel Disease Therapy Market Share by Application 2014-2019
    Figure Japan Inflammatory Bowel Disease Therapy Market Size 2014-2019 (Million US$)
    Table Japan Key Players Inflammatory Bowel Disease Therapy Revenue (2018-2019) (Million US$)
    Table Japan Key Players Inflammatory Bowel Disease Therapy Market Share (2018-2019)
    Table Japan Inflammatory Bowel Disease Therapy Market Size by Type 2014-2019 (Million US$)
    Table Japan Inflammatory Bowel Disease Therapy Market Share by Type 2014-2019
    Table Japan Inflammatory Bowel Disease Therapy Market Size by Application 2014-2019 (Million US$)
    Table Japan Inflammatory Bowel Disease Therapy Market Share by Application 2014-2019
    Figure Southeast Asia Inflammatory Bowel Disease Therapy Market Size 2014-2019 (Million US$)
    Table Southeast Asia Key Players Inflammatory Bowel Disease Therapy Revenue (2018-2019) (Million US$)
    Table Southeast Asia Key Players Inflammatory Bowel Disease Therapy Market Share (2018-2019)
    Table Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Type 2014-2019 (Million US$)
    Table Southeast Asia Inflammatory Bowel Disease Therapy Market Share by Type 2014-2019
    Table Southeast Asia Inflammatory Bowel Disease Therapy Market Size by Application 2014-2019 (Million US$)
    Table Southeast Asia Inflammatory Bowel Disease Therapy Market Share by Application 2014-2019
    Figure India Inflammatory Bowel Disease Therapy Market Size 2014-2019 (Million US$)
    Table India Key Players Inflammatory Bowel Disease Therapy Revenue (2018-2019) (Million US$)
    Table India Key Players Inflammatory Bowel Disease Therapy Market Share (2018-2019)
    Table India Inflammatory Bowel Disease Therapy Market Size by Type 2014-2019 (Million US$)
    Table India Inflammatory Bowel Disease Therapy Market Share by Type 2014-2019
    Table India Inflammatory Bowel Disease Therapy Market Size by Application 2014-2019 (Million US$)
    Table India Inflammatory Bowel Disease Therapy Market Share by Application 2014-2019
    Figure Central & South America Inflammatory Bowel Disease Therapy Market Size 2014-2019 (Million US$)
    Table Central & South America Key Players Inflammatory Bowel Disease Therapy Revenue (2018-2019) (Million US$)
    Table Central & South America Key Players Inflammatory Bowel Disease Therapy Market Share (2018-2019)
    Table Central & South America Inflammatory Bowel Disease Therapy Market Size by Type 2014-2019 (Million US$)
    Table Central & South America Inflammatory Bowel Disease Therapy Market Share by Type 2014-2019
    Table Central & South America Inflammatory Bowel Disease Therapy Market Size by Application 2014-2019 (Million US$)
    Table Central & South America Inflammatory Bowel Disease Therapy Market Share by Application 2014-2019
    Table Johnson & Johnson Company Details
    Table Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
    Figure Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
    Table Johnson & Johnson Recent Development
    Table AbbVie Company Details
    Table AbbVie Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
    Figure AbbVie Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
    Table AbbVie Recent Development
    Table Takeda Pharmaceutical Company Company Details
    Table Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
    Figure Takeda Pharmaceutical Company Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
    Table Takeda Pharmaceutical Company Recent Development
    Table Abbott Company Details
    Table Abbott Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
    Figure Abbott Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
    Table Abbott Recent Development
    Table Celgene Corporation Company Details
    Table Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
    Figure Celgene Corporation Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
    Table Celgene Corporation Recent Development
    Table Innovate Biopharma Company Details
    Table Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
    Figure Innovate Biopharma Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
    Table Innovate Biopharma Recent Development
    Table Cosmo Pharmaceuticals Company Details
    Table Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
    Figure Cosmo Pharmaceuticals Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
    Table Cosmo Pharmaceuticals Recent Development
    Table Gilead Sciences Company Details
    Table Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
    Figure Gilead Sciences Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
    Table Gilead Sciences Recent Development
    Table Pfizer Company Details
    Table Pfizer Revenue in Inflammatory Bowel Disease Therapy Business 2014-2019 (Million US$)
    Figure Pfizer Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2014-2019)
    Table Pfizer Recent Development
    Table Global Inflammatory Bowel Disease Therapy Market Size by Regions (Million US$) 2019-2025
    Figure Global Inflammatory Bowel Disease Therapy Market Size Share by Regions (2019-2025)
    Figure Global Inflammatory Bowel Disease Therapy Market Size Share by Regions in 2025
    Figure North America Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2025)(Million USD)
    Figure Europe Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2025)(Million USD)
    Figure China Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2025)(Million USD)
    Figure Japan Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2025)(Million USD)
    Figure Southeast Asia Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2025)(Million USD)
    Figure India Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2025)(Million USD)
    Figure Central & South America Inflammatory Bowel Disease Therapy Market Size Forecast (2019-2025)(Million USD)
    Table Global Inflammatory Bowel Disease Therapy Market Size by Product (2019-2025) (Million US$)
    Figure Global Inflammatory Bowel Disease Therapy Market Size by Product (2019-2025)
    Figure Global Inflammatory Bowel Disease Therapy Market Size by Product in 2025
    Table Global Inflammatory Bowel Disease Therapy Market Size by Application (2019-2025) (Million US$)
    Figure Global Inflammatory Bowel Disease Therapy Market Size by Application (2019-2025)
    Figure Global Inflammatory Bowel Disease Therapy Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3900

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Strategic Venue Partners
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Respiratory Infection Diagnostic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-39D3651
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Internal Neuromodulation Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-24F2529
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Colon Cancer Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-31C5944
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-10J13802
Mon Apr 15 00:00:00 UTC 2024

Add to Cart